BDNF gene delivery to the retina by cell adhesion peptide-conjugated Gemini Nanoplexes in vivo.

[1]  Y. Chau,et al.  Enhanced Delivery of siRNA to Retinal Ganglion Cells by Intravitreal Lipid Nanoparticles of Positive Charge. , 2020, Molecular pharmaceutics.

[2]  M. Foldvari,et al.  Dicationic Amino Substituted Gemini Surfactants and their Nanoplexes: Improved Synthesis and Characterization of Transfection Efficiency and Corneal Penetration In Vitro , 2020, Pharmaceutical Research.

[3]  M. Foldvari,et al.  Multipotent stem cell-derived retinal ganglion cells in 3D culture as tools for neurotrophic factor gene delivery system development. , 2019, Nanomedicine : nanotechnology, biology, and medicine.

[4]  M. Foldvari,et al.  Retinal Multipotent Stem-Cell Derived “MiEye” Spheroid 3D Culture Model for Preclinical Screening of Non-viral Gene Delivery Systems , 2018, Precision Nanomedicine.

[5]  R. Ritch,et al.  Glaucoma , 2017, The Lancet.

[6]  M. Filla,et al.  The role of integrins in glaucoma , 2017, Experimental eye research.

[7]  M. Foldvari,et al.  In vitro bioassay model for screening non-viral neurotrophic factor gene delivery systems for glaucoma treatment , 2016, Drug Delivery and Translational Research.

[8]  A. Tonevitsky,et al.  L1CAM: Cell adhesion and more. , 2016, Progress in histochemistry and cytochemistry.

[9]  M. Foldvari,et al.  The intricacies of neurotrophic factor therapy for retinal ganglion cell rescue in glaucoma: a case for gene therapy , 2016, Neural regeneration research.

[10]  R. Verrall,et al.  Di-Peptide-Modified Gemini Surfactants as Gene Delivery Vectors: Exploring the Role of the Alkyl Tail in Their Physicochemical Behavior and Biological Activity , 2016, The AAPS Journal.

[11]  D. Barloscio,et al.  Rescue of Retinal Function by BDNF in a Mouse Model of Glaucoma , 2014, PloS one.

[12]  J. Sivak,et al.  Preclinical development and ocular biodistribution of gemini-DNA nanoparticles after intravitreal and topical administration: towards non-invasive glaucoma gene therapy. , 2014, Nanomedicine : nanotechnology, biology, and medicine.

[13]  C. Morais,et al.  Bis-quaternary gemini surfactants as components of nonviral gene delivery systems: a comprehensive study from physicochemical properties to membrane interactions. , 2014, International journal of pharmaceutics.

[14]  Eric C Freeman,et al.  Modeling the proton sponge hypothesis: examining proton sponge effectiveness for enhancing intracellular gene delivery through multiscale modeling , 2013, Journal of biomaterials science. Polymer edition.

[15]  Shannon M. Conley,et al.  Comparative Analysis of DNA Nanoparticles and AAVs for Ocular Gene Delivery , 2012, PloS one.

[16]  Hwa Sun Kim,et al.  Stem cell-based delivery of brain-derived neurotrophic factor gene in the rat retina , 2012, Brain Research.

[17]  M. Foldvari,et al.  Designing pH-sensitive gemini nanoparticles for non-viral gene delivery into keratinocytes , 2012 .

[18]  Yoko Furukawa-Hibi,et al.  Periocular injection of in situ hydrogels containing Leu-Ile, an inducer for neurotrophic factors, promotes retinal ganglion cell survival after optic nerve injury. , 2011, Experimental eye research.

[19]  K. Martin,et al.  Neurotrophic factor delivery as a protective treatment for glaucoma. , 2011, Experimental eye research.

[20]  Peng Yang,et al.  Amino acid-substituted gemini surfactant-based nanoparticles as safe and versatile gene delivery agents. , 2011, Current drug delivery.

[21]  M. Foldvari,et al.  Advancing nonviral gene delivery: lipid- and surfactant-based nanoparticle design strategies. , 2010, Nanomedicine.

[22]  Gaurav Sahay,et al.  Endocytosis of nanomedicines. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[23]  M. Foldvari,et al.  Enhanced gene expression in epithelial cells transfected with amino acid-substituted gemini nanoparticles. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[24]  Danyi Wang,et al.  Mechanisms of retinal ganglion cell injury and defense in glaucoma. , 2010, Experimental eye research.

[25]  W. Thoreson,et al.  Induced Pluripotent Stem Cells Generate Both Retinal Ganglion Cells and Photoreceptors: Therapeutic Implications in Degenerative Changes in Glaucoma and Age‐Related Macular Degeneration , 2010, Stem cells.

[26]  Francesco Stellacci,et al.  Effect of surface properties on nanoparticle-cell interactions. , 2010, Small.

[27]  P. Davis,et al.  Cell surface nucleolin serves as receptor for DNA nanoparticles composed of pegylated polylysine and DNA. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[28]  M. Foldvari,et al.  Structural and transfection properties of amine‐substituted gemini surfactant‐based nanoparticles , 2007, The journal of gene medicine.

[29]  J. Morrison,et al.  Global changes in optic nerve head gene expression after exposure to elevated intraocular pressure in a rat glaucoma model. , 2007, Investigative ophthalmology & visual science.

[30]  M. Foldvari,et al.  Thermodynamic and aggregation properties of aza- and imino-substituted gemini surfactants designed for gene delivery. , 2007, Physical chemistry chemical physics : PCCP.

[31]  H. Quigley,et al.  The number of people with glaucoma worldwide in 2010 and 2020 , 2006, British Journal of Ophthalmology.

[32]  W. Hsu,et al.  Induction of vitronectin and integrin alphav in the retina after optic nerve injury. , 2006, Molecular vision.

[33]  M. Baca-Estrada,et al.  In vivo cutaneous interferon‐γ gene delivery using novel dicationic (gemini) surfactant–plasmid complexes , 2005, The journal of gene medicine.

[34]  K. Thelen,et al.  The cell adhesion molecule NrCAM is crucial for growth cone behaviour and pathfinding of retinal ganglion cell axons , 2005, Development.

[35]  H. Yip,et al.  Different optic nerve injury sites result in different responses of retinal ganglion cells to brain-derived neurotrophic factor but not neurotrophin-4/5 , 2005, Brain Research.

[36]  H. Yip,et al.  CNTF and BDNF have similar effects on retinal ganglion cell survival but differential effects on nitric oxide synthase expression soon after optic nerve injury. , 2005, Investigative ophthalmology & visual science.

[37]  A. Nitta,et al.  Hydrophobic dipeptide Leu‐Ile protects against neuronal death by inducing brain‐derived neurotrophic factor and glial cell line‐derived neurotrophic factor synthesis , 2004, Journal of neuroscience research.

[38]  M. Foldvari,et al.  Targeting of liposomes to melanoma cells with high levels of ICAM-1 expression through adhesive peptides from immunoglobulin domains. , 2002, Journal of pharmaceutical sciences.

[39]  M. Foldvari,et al.  Targeting of Liposomes to Human Keratinocytes Through Adhesive Peptides from Immunoglobulin Domains in the Presence of IFNM-γ , 2002, Drug delivery.

[40]  C. Hetz,et al.  Thy-1 binds to integrin β3 on astrocytes and triggers formation of focal contact sites , 2001, Current Biology.

[41]  D. Zack,et al.  Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma. , 2000, Investigative ophthalmology & visual science.

[42]  S. Bass,et al.  Crystal structures of the neurotrophin-binding domain of TrkA, TrkB and TrkC. , 1999, Journal of molecular biology.

[43]  B. Barres,et al.  Retinal Ganglion Cells Lose Trophic Responsiveness after Axotomy , 1999, Neuron.

[44]  Q. Yan,et al.  Glial cell line-derived neurotrophic factor (GDNF) promotes the survival of axotomized retinal ganglion cells in adult rats: comparison to and combination with brain-derived neurotrophic factor (BDNF). , 1999, Journal of neurobiology.

[45]  A. Di Polo,et al.  Prolonged delivery of brain-derived neurotrophic factor by adenovirus-infected Müller cells temporarily rescues injured retinal ganglion cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[46]  D O Frost,et al.  BDNF Injected into the Superior Colliculus Reduces Developmental Retinal Ganglion Cell Death , 1998, The Journal of Neuroscience.

[47]  C. Stuermer,et al.  Axon-Regenerating Retinal Ganglion Cells in Adult Rats Synthesize the Cell Adhesion Molecule L1 but Not TAG-1 or SC-1 , 1997, Molecular and Cellular Neuroscience.

[48]  D. Cheresh,et al.  A Single Immunoglobulin-like Domain of the Human Neural Cell Adhesion Molecule L1 Supports Adhesion by Multiple Vascular and Platelet Integrins , 1997, The Journal of cell biology.

[49]  S. Elner,et al.  The integrin superfamily and the eye. , 1996, Investigative ophthalmology & visual science.

[50]  M. Cerro,et al.  Retinal ganglion cell survival is promoted by genetically modified astrocytes designed to secrete brain-derived neurotrophic factor (BDNF) , 1994, Brain Research.

[51]  D. B. Clarke,et al.  Effects of ocular injury and administration of brain-derived neurotrophic factor on survival and regrowth of axotomized retinal ganglion cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[52]  M. Schachner.  Cell Surface Recognition and Neuron‐Glia Interactions a , 1991, Annals of the New York Academy of Sciences.

[53]  M. Foldvari,et al.  Intracellular delivery of drugs by liposomes containing P0 glycoprotein from peripheral nerve myelin into human M21 melanoma cells. , 1991, Journal of pharmaceutical sciences.

[54]  M. Schwab,et al.  Brain-derived neurotrophic factor supports the survival of cultured rat retinal ganglion cells , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[55]  T. Borrás.  The Pathway From Genes to Gene Therapy in Glaucoma: A Review of Possibilities for Using Genes as Glaucoma Drugs , 2017, Asia-Pacific journal of ophthalmology.

[56]  Nana Zhao,et al.  The shape and size effects of polycation functionalized silica nanoparticles on gene transfection. , 2015, Acta biomaterialia.

[57]  P. Schneider,et al.  DIRECT THY-1/αvβ3 INTEGRIN INTERACTION MEDIATES NEURON TO ASTROCYTE COMMUNICATION , 2008 .

[58]  L. Tönges,et al.  ROCK inhibition and CNTF interact on intrinsic signalling pathways and differentially regulate survival and regeneration in retinal ganglion cells. , 2008, Brain : a journal of neurology.

[59]  M. Schachner,et al.  Neural recognition molecules of the immunoglobulin superfamily: signaling transducers of axon guidance and neuronal migration , 2006, Nature Neuroscience.

[60]  M. Foldvari,et al.  P0 protein mediated targeting of liposomes to melanoma cells with high level of ICAM-1 expression. , 1999, Journal of drug targeting.

[61]  M. Jaafari,et al.  Targeting liposomes through immunoglobulin superfamily domains: P0 protein as a model. , 1998, Drug delivery.